Market Announcement 12 February 2024 Elixinol Wellness Limited (ASX: EXL) – Trading Halt Description The securities of Elixinol Wellness Limited (‘EXL’) will be placed in trading halt at the request of EXL, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 14 February 2024 or when the announcement is released to the market. Issued by ASX Compliance 12 February 2024 ASX Limited #10689656v1 Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au 12 February 2024 Lachlan Morley ASX Listing Advisor Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 By email: Lachlan.Morley@asx.com.au; tradinghaltssydney@asx.com.au Dear Lachlan, Elixinol Wellness Limited (ASX:EXL) – Request for trading halt In accordance with Listing Rule 17.1, Elixinol Wellness Limited (ACN 621 479 794) (Elixinol Wellness) requests a trading halt be granted by the Australian Securities Exchanges (ASX) in respect of EXL’s ordinary shares from the commencement of trading on Monday, 12 February 2024. For the purposes of Listing Rule 17.1, Elixinol Wellness provides the following information: 1) Elixinol Wellness is seeking the trading halt pending an announcement by Elixinol Wellness to the ASX in connection with a capital raising; 2) Elixinol Wellness requests that the trading halt remain in place until the earlier of Elixinol Wellness making an announcement to the market regarding the capital raising and the commencement of trading on Wednesday, 14 February 2024; 3) Elixinol Wellness is not aware of any reason why the trading halt should not be granted, or of any other information necessary to inform the market about the trading halt. This announcement has been approved by the Elixinol Wellness Board of Directors. Yours sincerely Josephine Lorenz Joint Company Secretary Elixinol Wellness Limited